Definium Therapeutics is a late-stage clinical biopharmaceutical company focused on developing accessible treatments for psychiatric disorders using psychedelics. Our lead product candidate, lysergide tartrate, targets generalized anxiety, major depressive disorder, and posttraumatic stress disorder. We are also developing DT402 for the core symptoms of autism spectrum disorder. Our mission is to advance a new generation of therapeutics for psychiatric and neurological disorders, aiming to transform mental health care. Headquartered in New York and trading on Nasdaq (DFTX), we are seeking to move psychiatry forward into a boundless future.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director